Therapy and Clinical Studies

48 Items

All Items

Neoadjuvant stereotactic radiosurgery for brain metastases: Current evidence and clinical perspectives

Aybala Nur Ucgul, Ahmet Oguz Tugcu, Ozge Petek Erpolat

377–382
Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety

Xiaomin Wang, Bingxu Li, Zhiyong Zheng, Weijie Wang

2127–2138
Molecular basis and therapeutic targets in prostate cancer: A comprehensive review

Florentina Claudia Militaru, Valentin Militaru, Nicolae Crisan, Ioana Corina Bocsan, Anghel Adrian Udrea, Andreea Catana, Eniko Kutasi, Mariela Sanda Militaru

760–771
Molecular and immune characteristics of neuroendocrine bladder carcinoma — Implications for diagnosis, prognosis, and therapy: A review

Tianxiang Zhang, Xi Zhang, Lei Qian, Chunjiang Hu, Jianxing Li
Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy

Pengcheng Chen, Liang Wang, Xun Yang, Jifeng Feng

159–169
Lymph node dissection before initial treatment for locally advanced cervical cancer: A systematic review and meta-analysis

He Zhang, Miao Ao, You Wu, Wei Mao, Haixia Luo, Kunyu Wang, Bin Li

1463–1469
Is hepatic resection always a better choice than radiofrequency ablation for solitary hepatocellular carcinoma regardless of age and tumor size?

Shicong Zeng, Yao Zhang, Zongwen Wang, Xiaohang Ren, Jingtao Li, Shuoheng Ma, Wenyu Liu, Qiankun Zhu, Yan Yan, Bo Zhai

705–717
Intrinsic resistance and efficacy of immunotherapy in microsatellite instability-high colorectal cancer: A systematic review and meta-analysis

Ren Wang, Jie Lian, Xin Wang, Xiangyi Pang, Benjie Xu, Shuli Tang, Jiayue Shao, Haibo Lu

198–208
Intensity modulated radiation therapy for elderly patients with esophageal cancer: Our experience

Dan Li, Xiaoxiao Liu, Yuchen Wang, Yingying Jin, Fang Li, Hongbing Ma

327–334
Influence of cervical treatment methods on subsequent vaginal lesions: A study of HPV-related neoplasia

Yuanyuan Chen, Haizhen He, Xiaoxi Wang, Yan Ye, Jiajia Pan

1595–1605
Impact of thyroid immune-related adverse events on clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy: A single center study

Šejla Cerić, Timur Cerić, Emir Sokolović, Jasmina Dalač, Dragana Miletić, Inga Marijanović, Layan Mattar, Amina Aljić, Selma Agić-Bilalagić, Amera Šadija, Miran Hadžiahmetović, Semir Bešlija

144–149
Impact of the COVID-19 pandemic on management of surgically treated laryngeal squamous cell carcinoma

Alexander Lein, David T. Liu, Markus Haas, Almir Salkic, Azra Ibrisevic, Sabrina Uscuplic, Alen Harcinovic, Taria Brkic, Thomas Thurner, Faris F. Brkic

188–195
Global Immune-Nutrition-Inflammation Index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients

Efsun Somay, Erkan Topkan, Sibel Bascil, Nilüfer Kılıc Durankuş, Şükran Senyürek, Düriye Ozturk, Berrin Pehlivan, Ugur Selek

1703–1710
Exploring the therapeutic potential of diterpenes in gastric cancer: Mechanisms, efficacy, and clinical prospects

Chenhui Ma, Lei Gao, Kewei Song, Baohong Gu, Bofang Wang, Weigao Pu, Hao Chen

1–15
Endometrial mesonephric-like adenocarcinoma: Clinicopathologic features, treatment, and outcomes

Shuping Yan, Yanpeng Tian, Mingyue Li, Xiaonan Wang, Jiayi Wang, Kuisheng Chen, Tianjiao Lai, Ye Zhang, Xixaoxiao Zhang, Yana Liu, Yuxi Jin, Xueyan Liu, Meng Mao, Qian Wang, Ruixia Guo
Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer

Weiwei Li, Mohan Dong, Shigao Huang, Liu Shi , Hua Yang, Ying Zhang, Jie Gong, Mei Shi, Lichun Wei, Lina Zhao

310–316
Efficacy and safety of CalliSpheres drug-eluting bead bronchial arterial infusion chemoembolization vs. bland embolization in advanced lung cancer with hemoptysis: A multicenter retrospective study

Song Liu, Maoli Yin, Song Liu, Huichao Xu, Guangji Yu, Xianchuang Liu, Guimin Chen, Weiwei Zhang
$Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients$

Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients

Hua Yang, Shi Gao Huang, Mohan Dong, Xiaomeng Wang, JunHua He, Huyan Su, Changhao Liu, Yong Zhu, Lichun Wei, Zi Liu

1586–1594
Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer

Qiusheng Guo, Tian Lan, Yunyan Lu, Zujian Hu, Haibin Xu, Xiaojia Wang, Xiying Shao, Xueyan Fu

502–509
Effect of vascular endothelial growth factor rs35569394 in esophageal cancer and response to chemotherapy

Zishan Wang, Chenwei Li, Xinjian Li, Jianguang Shi, Weijie Wu

271–276

Previous 21-40 of 48 Next